Jafron BiomedicalLtd Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 300529?
Owner Type	Number of Shares	Ownership Percentage
Employee Share Scheme	10,597,782	1.37%
Institutions	88,215,352	11.4%
General Public	277,212,718	35.8%
Individual Insiders	398,336,519	51.4%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 62.63% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
45.9%	Fan Dong	355,131,867	CN¥10.7b	0%	no data
2.76%	Xian Min Tang	21,336,425	CN¥641.4m	-0.15%	no data
1.82%	Hwabao WP Fund Management Co., Ltd	14,061,881	CN¥422.7m	0%	0.37%
1.37%	Jafron Biomedical Co.,Ltd., ESOP	10,597,782	CN¥318.6m	0%	no data
1.15%	E Fund Management Co., Ltd.	8,887,599	CN¥267.2m	0%	0.04%
1.04%	Invesco Great Wall Fund Management Co. Ltd	8,084,154	CN¥243.0m	0%	0.15%
1.04%	China Merchants Fund Management Company Ltd.	8,065,186	CN¥242.4m	0%	0.14%
1.04%	Xue Guo	8,040,792	CN¥241.7m	0.43%	no data
0.85%	Tianhong Asset Management Co., Ltd.	6,598,567	CN¥198.4m	0%	0.13%
0.73%	China Southern Asset Management Co., Ltd.	5,679,500	CN¥170.7m	0%	0.06%
0.73%	Guang Hai Zhang	5,630,187	CN¥169.2m	0%	no data
0.7%	China Asset Management Co. Ltd.	5,442,861	CN¥163.6m	0%	0.02%
0.49%	GF Fund Management Co., Ltd.	3,821,135	CN¥114.9m	0%	0.03%
0.46%	De Zhi Li	3,540,877	CN¥106.4m	0%	no data
0.4%	Lihua Fang	3,096,105	CN¥93.1m	0%	no data
0.27%	Bosera Asset Management Co., Ltd.	2,074,940	CN¥62.4m	0%	0.04%
0.26%	The Vanguard Group, Inc.	1,985,842	CN¥59.7m	-0.01%	no data
0.26%	First State Cinda Fund Management Company Limited	1,983,700	CN¥59.6m	0%	0.14%
0.25%	Guotai Asset Management Company Limited	1,944,655	CN¥58.5m	0%	0.03%
0.23%	Everbright Pramerica Fund Management Co. Ltd.	1,799,339	CN¥54.1m	0%	0.47%
0.23%	China Universal Asset Management Company Ltd.	1,776,399	CN¥53.4m	0%	0.02%
0.19%	Harvest Fund Management Co. Ltd.	1,478,934	CN¥44.5m	0%	0.01%
0.18%	Maxwealth Fund Management Co., Ltd	1,402,398	CN¥42.2m	0%	0.25%
0.17%	Wanjia Asset Management Co., Ltd.	1,304,126	CN¥39.2m	0%	0.06%
0.16%	Hotland Innovation Asset Management Co., Ltd.	1,206,700	CN¥36.3m	0%	2.18%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/19 22:36
End of Day Share Price	2024/12/19 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Jafron Biomedical Co.,Ltd. is covered by 9 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Sophia Zhang	China Stock Investment Research Co. Ltd. (GZ500..com)
Shuo Song	Citic Securities Co., Ltd.
Xiao Wei Lin	Everbright Securities Co. Ltd.